Generation Bio
GBIO
GBIO
95 hedge funds and large institutions have $223M invested in Generation Bio in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 41 increasing their positions, 28 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
14% less funds holding
Funds holding: 111 → 95 (-16)
27% less capital invested
Capital invested by funds: $306M → $223M (-$83.6M)
60% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 25
Holders
95
Holding in Top 10
1
Calls
$67K
Puts
$4K
Top Buyers
| 1 | +$1.08M | |
| 2 | +$1.08M | |
| 3 | +$1.02M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$776K |
| 5 |
YCM
Yiheng Capital Management
San Francisco,
California
|
+$741K |
Top Sellers
| 1 | -$4.91M | |
| 2 | -$1.02M | |
| 3 | -$529K | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$434K |
| 5 |
HS
HighVista Strategies
Boston,
Massachusetts
|
-$433K |